J Moore1,2, T Price3, S Carruthers4, S Selva-Nayagam5, A Luck6, M Thomas1,2, P Hewett2,7. 1. Department of Colorectal Surgery, Royal Adelaide Hospital, Adelaide, South Australia, Australia. 2. Department of Surgery, University of Adelaide, Adelaide, South Australia, Australia. 3. Department of Medical Oncology, Queen Elizabeth Hospital, Adelaide, South Australia, Australia. 4. Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia. 5. Department of Medical Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia. 6. Department of Colorectal Surgery, Lyell McEwen Health Service, Adelaide, South Australia, Australia. 7. Department of Colorectal Surgery, Queen Elizabeth Hospital, Adelaide, South Australia, Australia.
Abstract
AIM: The aim was to determine whether the addition of additional cycles of chemotherapy during the 'wait period' following neoadjuvant chemoradiotherapy for rectal cancer improves the pathological complete response (pCR) rate. METHOD:Rectal cancer patients were randomly allocated either to a standard 10 week wait period before surgery (standard chemoradiotherapy, SCRT) or to receive three cycles of fluorouracil based chemotherapy following chemoradiotherapy during a similar 10 week wait (extended chemoradiotherapy, XCRT). The primary end-point was pCR as determined by blinded pathological assessment. RESULTS:Forty-nine patients were randomized (SCRTn = 24, XCRTn = 25). pCR occurred in 10 patients overall but there was no significant difference in pCR between the groups (SCRTn = 6, XCRTn = 4, P = 0.49). CONCLUSION: The addition of three cycles of 5-fluorouracil/leucovorin in a 10 week wait period after conventional chemoradiotherapy seems to result in similar pCR rates in patients with locally advanced rectal cancer based on this small randomized trial. Colorectal Disease
RCT Entities:
AIM: The aim was to determine whether the addition of additional cycles of chemotherapy during the 'wait period' following neoadjuvant chemoradiotherapy for rectal cancer improves the pathological complete response (pCR) rate. METHOD:Rectal cancerpatients were randomly allocated either to a standard 10 week wait period before surgery (standard chemoradiotherapy, SCRT) or to receive three cycles of fluorouracil based chemotherapy following chemoradiotherapy during a similar 10 week wait (extended chemoradiotherapy, XCRT). The primary end-point was pCR as determined by blinded pathological assessment. RESULTS: Forty-nine patients were randomized (SCRTn = 24, XCRTn = 25). pCR occurred in 10 patients overall but there was no significant difference in pCR between the groups (SCRTn = 6, XCRTn = 4, P = 0.49). CONCLUSION: The addition of three cycles of 5-fluorouracil/leucovorin in a 10 week wait period after conventional chemoradiotherapy seems to result in similar pCR rates in patients with locally advanced rectal cancer based on this small randomized trial. Colorectal Disease
Authors: Andrea M Guida; Bruno Sensi; Vincenzo Formica; Rolando M D'Angelillo; Mario Roselli; Giovanna Del Vecchio Blanco; Piero Rossi; Gabriella T Capolupo; Marco Caricato; Giuseppe S Sica Journal: Biol Direct Date: 2022-06-13 Impact factor: 7.173
Authors: Hamid Nasrolahi; Sepideh Mirzaei; Mohammad Mohammadianpanah; Ali Mohammad Bananzadeh; Maral Mokhtari; Mohammad Reza Sasani; Ahmad Mosalaei; Shapour Omidvari; Mansour Ansari; Niloofar Ahmadloo; Seyed Hasan Hamedi; Nezhat Khanjani Journal: Ann Coloproctol Date: 2019-10-31
Authors: S Hoendervangers; J P M Burbach; M M Lacle; M Koopman; W M U van Grevenstein; M P W Intven; H M Verkooijen Journal: Ann Surg Oncol Date: 2020-06-10 Impact factor: 5.344
Authors: Maria C Riesco-Martinez; Carlos Fernandez-Martos; Cristina Gravalos-Castro; Paula Espinosa-Olarte; Anna La Salvia; Luis Robles-Diaz; Andrea Modrego-Sanchez; Rocio Garcia-Carbonero Journal: Cancers (Basel) Date: 2020-12-05 Impact factor: 6.639